Neuroscience

First blood-based in vitro diagnostic test to receive FDA clearance to help identify patients with amyloid pathology associated with Alzheimer’s disease

New test provides less invasive option, reduces reliance on PET scans, and increases diagnosis accessibility

In a proof-of-concept study, the test detected five key biomarkers of Alzheimer’s disease—more than current commercially available blood tests can measure

Even small tissue samples can yield additional insights into a tumor’s biology, immune interactions, and molecular pathways

Prior to the MSDA Test, disease management in MS relied primarily on clinical assessments and MRI

VeraBIND™ Tau is a new noninvasive test that offers 96 percent sensitivity and 90 percent specificity, empowering earlier and more accessible Alzheimer's detection

New treatments are moving away from open surgery and toward minimally invasive techniques

Potential new therapy for childhood brain cancer is effective in infiltrating, killing tumor cells in preclinical models in mice

The study identified several drugs already licensed and in use that have the potential to be repurposed to treat dementia.

Study suggests the number of US adults who will probably develop dementia each year will increase from around 514,000 in 2020 to approximately 1 million in 2060

By linking epilepsy to specific genetic mutations, the research offers a new framework for understanding the disorder and developing therapies that address its root causes

The new molecular findings are essential for further developing diagnostic tools and imaging techniques to detect and monitor Huntington’s disease

Better diagnostics for neurodegenerative diseases can improve clinical trials to help move groundbreaking therapies to approval

UCLA researchers look to create point-of-care test that can confirm diagnosis at the bedside

New research identifies a critical genetic variation in Group 3 medulloblastomas, paving the way for improved diagnostic and treatment strategies for this challenging form of pediatric brain cancer

A new study finds that inherited neurological conditions may be three times more common than previously thought, reshaping genetic testing and diagnostic practices

Trailblazing labs are among the first to adopt new tests and treatments for longstanding challenges

Mount Sinai Health System among the first in the world to use blood tests as an early detection tool for Alzheimer’s disease and related dementias in patients

Analysis of microRNA sequences from hundreds of patient samples allowed researchers to develop a unique “ALS fingerprint”

Join Today's Clinical Lab, G2 Intelligence and  Christine P. Bump to learn about Loper Bright and the Potential Impact on the Laboratory Industry